Kawthar BOUCHEMAL's Home page
Kawthar BOUCHEMAL is associate Professor at the University of Paris Saclay in the field of colloids, biomaterials and nanotechnology.
After a pharmacist graduate diploma, she completed a Master’s Degree in Medical and Biological Engineering and a PhD in Pharmaceutical Nanotechnology at the University of Claude Bernard Lyon-1. She was post-doctoral fellow jointly at the University of Claude Bernard Lyon-1 and the University of Geneva in Switzerland. In 2015, she has been appointed to the Institut Universitaire de France (IUF), in recognition of her teaching and research activities.
Her research activities are focused on conception, characterization, and evaluation of the behaviors of pharmaceutical compositions able to improve the efficacy and/or decrease the side effects of pharmaceutical drugs. Her work has led to novel environmentally responsive controlled release formulations and a series of bio- and mucoadhesive devices. Her group has provided the fundamental basis for a rational use of thermosensitive and mucoadhesive hydrogels for the prevention of the transmission of viral infections by mucosal routes. Her research on self-associating biopolymers and cyclodextrins has led to the development of new self-assembling micro- and nanosystems which have proven useful for the prevention and the treatment of microbial infections. Other research work deals with scaling-up the production of drug delivery systems. Her group has established a mathematical model between nano-emulsion droplet size and turbulences created upon nano-emulsion formation by emulsification and solvent diffusion process, so called the Ouzo effect.
Kawthar BOUCHEMAL is author & co-author of 78 publications and inventor of 16 patents. She serves in the editorial board of Pharmaceutical Research journal and was guest editor of the International Journal of Pharmaceutics. She was chair and/or member of the Organizing & Scientific committee of national and international meetings on Pharmaceutics & Biopharmaceutics.
In 2014, she co-founded a biotech company aiming to move her research from the laboratory to the clinic. She has been attributed the award for The Best Innovative Company by the French Minister of Higher Education and Research in 2013 and in 2016. She is founder and director a Master's degree program focused on the Protection and Management of Innovation in Health.